Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn
Rapid CommunicationShort Communication

Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor Activation

Albert Braeuning, Ferdinand Kollotzek, Eva Zeller, Thomas Knorpp, Markus F. Templin and Michael Schwarz
Drug Metabolism and Disposition November 2018, 46 (11) 1462-1465; DOI: https://doi.org/10.1124/dmd.118.083014
Albert Braeuning
Department of Toxicology, University of Tübingen, Tübingen, Germany (A.B., F.K., E.Z., M.S.); Natural and Medical Sciences Institute, Reutlingen, Germany (T.K., M.F.T.); and Department Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany (A.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferdinand Kollotzek
Department of Toxicology, University of Tübingen, Tübingen, Germany (A.B., F.K., E.Z., M.S.); Natural and Medical Sciences Institute, Reutlingen, Germany (T.K., M.F.T.); and Department Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany (A.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva Zeller
Department of Toxicology, University of Tübingen, Tübingen, Germany (A.B., F.K., E.Z., M.S.); Natural and Medical Sciences Institute, Reutlingen, Germany (T.K., M.F.T.); and Department Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany (A.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Knorpp
Department of Toxicology, University of Tübingen, Tübingen, Germany (A.B., F.K., E.Z., M.S.); Natural and Medical Sciences Institute, Reutlingen, Germany (T.K., M.F.T.); and Department Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany (A.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Markus F. Templin
Department of Toxicology, University of Tübingen, Tübingen, Germany (A.B., F.K., E.Z., M.S.); Natural and Medical Sciences Institute, Reutlingen, Germany (T.K., M.F.T.); and Department Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany (A.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Schwarz
Department of Toxicology, University of Tübingen, Tübingen, Germany (A.B., F.K., E.Z., M.S.); Natural and Medical Sciences Institute, Reutlingen, Germany (T.K., M.F.T.); and Department Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany (A.B.)
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

vol. 46 no. 11 1462-1465
DOI 
https://doi.org/10.1124/dmd.118.083014
PubMed 
30115646

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Received June 14, 2018
  • Accepted August 14, 2018
  • Published online October 12, 2018.

Article Versions

  • Earlier version (August 16, 2018 - 09:36).
  • You are viewing the most recent version of this article.
Copyright & Usage 
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Albert Braeuning,
  2. Ferdinand Kollotzek,
  3. Eva Zeller,
  4. Thomas Knorpp,
  5. Markus F. Templin, and
  6. Michael Schwarz
  1. Department of Toxicology, University of Tübingen, Tübingen, Germany (A.B., F.K., E.Z., M.S.); Natural and Medical Sciences Institute, Reutlingen, Germany (T.K., M.F.T.); and Department Food Safety, German Federal Institute for Risk Assessment, Berlin, Germany (A.B.)
  1. Address correspondence to:
    Dr. Albert Braeuning, Department Food Safety, German Federal Institute for Risk Assessment, Max-Dohrn-Str. 8-10, 10589 Berlin, Germany. E-mail: Albert.Braeuning{at}bfr.bund.de
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2018 to March 2023

AbstractFullPdf
Aug 20182781096
Sep 2018331020
Oct 20182141725
Nov 201849612
Dec 20183236
Jan 20192237
Feb 20192666
Mar 201947716
Apr 20192778
May 20194249
Jun 20191319
Jul 20191729
Aug 20192314
Oct 20191186
Nov 201921818
Dec 201922112
Jan 202061211
Feb 20202129
Mar 20200526
May 20204137
Jun 20204147
Jul 20200146
Aug 2020197
Sep 2020365
Oct 202031913
Nov 202051115
Dec 20207136
Jan 202131811
Feb 20214158
Mar 2021674
Apr 20217179
May 2021181112
Jun 20214127
Jul 20212227
Aug 20211188
Sep 20215915
Oct 202141527
Nov 20210920
Dec 20210107
Jan 20222613
Feb 2022236
Mar 202221311
Apr 2022273
May 2022258
Jun 202221111
Jul 202251538
Aug 20226714
Sep 2022256
Oct 202271924
Nov 20222713
Dec 20222615
Jan 202331011
Feb 20232817
Mar 20231128

PreviousNext
Back to top

In this issue

Drug Metabolism and Disposition: 46 (11)
Drug Metabolism and Disposition
Vol. 46, Issue 11
1 Nov 2018
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Drug Metabolism & Disposition article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Mouse Hepatomas with Ha-ras and B-raf Mutations Differ in Mitogen-Activated Protein Kinase Signaling and Response to Constitutive Androstane Receptor Activation
(Your Name) has forwarded a page to you from Drug Metabolism & Disposition
(Your Name) thought you would be interested in this article in Drug Metabolism & Disposition.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Rapid CommunicationShort Communication

CAR Activation in Ha-ras- and B-raf-Mutated Mouse Hepatoma

Albert Braeuning, Ferdinand Kollotzek, Eva Zeller, Thomas Knorpp, Markus F. Templin and Michael Schwarz
Drug Metabolism and Disposition November 1, 2018, 46 (11) 1462-1465; DOI: https://doi.org/10.1124/dmd.118.083014

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Rapid CommunicationShort Communication

CAR Activation in Ha-ras- and B-raf-Mutated Mouse Hepatoma

Albert Braeuning, Ferdinand Kollotzek, Eva Zeller, Thomas Knorpp, Markus F. Templin and Michael Schwarz
Drug Metabolism and Disposition November 1, 2018, 46 (11) 1462-1465; DOI: https://doi.org/10.1124/dmd.118.083014
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Authorship Contributions
    • Footnotes
    • Abbreviations
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Preincubation Effects on Inhibition of OCT1 by CsA
  • Carbamazepine Metabolite and Hypersensitivity Reactions
  • SULT4A1 Preserves Mitochondrial Function
Show more Short Communication

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics